Specialties

Nearly 90 percent of the study subjects had a history of high blood pressure, but more than 25 percent did not take medication to control it.

Bone structure abnormalities and impaired foot and ankle biomechanics in diabetic patients are key risk factors for development of serious ulcers.

New study using a genetic growth factor to repair diabetes-damaged nerves begins.

Results of a landmark trial of 1,000.

The advanced glycation end product (AGE) inhibitor Pyridorin (pyridoxamine dihydrochloride) has potential in treating diabetic nephropathy.

Reducing systolic blood pressure is critical to slowing the progression of diabetic renal disease, researchers stated at the 35th annual meeting of the American Society of Nephrology (ASN) last week.

Similar issues arise with the approach toward dyslipidemia. Niacin is effective in reducing TGs and raising HDL but it can increase insulin resistance and deteriorate glycemic control 254, 255 . Nicotinic acid, cholestyramine, fenofibrate and possibly clofibrate increase the concentrations of homocysteine, an independent risk factor for CHD 256, 257 …

Insulin resistance, a condition commonly associated with the development of type 2 diabetes, is likely a major cause of kidney disease, or nephropathy, in people with type 1 diabetes.

Anemia affects a significant proportion of people with diabetes and is a key indicator of early kidney disease.

When patients with diabetes and kidney disease were treated with Avapro the risk of progression of their nephropathy or death was 20 percent lower.